Aveanna Healthcare Holdings: Strong Q4 2025 Earnings and Strategic Growth Initiatives Poised to Drive Shareholder Value

Key Highlights from the Q4 2025 Investor Presentation

• Record Revenue and EBITDA Growth: Aveanna Healthcare Holdings, Inc. (“Aveanna”) reported robust financial results for Q4 2025, with consolidated revenue reaching \$662.5 million, up 27.4% year-over-year. Adjusted EBITDA surged to \$85.0 million, reflecting an impressive 54.0% year-over-year growth.
• Segment Performance:
  • Private Duty Services (PDS): Q4 2025 revenue growth of 28.1% driven by 12.4 million hours of care provided, a 17.9% increase in volume compared to the previous year.
  • Medical Solutions (MS): Unique patients served (UPS) grew by 3.4%, totaling 92,000 unique patients for the quarter.
  • Home Health & Hospice (HHH): Revenue grew 27.3% year-over-year, with 14,000 total episodes—a 25.0% increase in volume.
• Strong Cash Flow and Liquidity:
  • Operating cash flow for 2025 stood at \$125.9 million, with free cash flow of \$131.0 million.
  • Liquidity at year-end was \$528.8 million, including \$193.3 million in cash, \$225.5 million in revolver availability, and \$110 million in securitization availability.
  • Total variable rate debt amounts to \$1.487 billion, with significant hedging in place to manage interest rate risk.
• 2026 Guidance:
  • Revenue expected in the range of \$2.54 billion to \$2.56 billion.
  • Adjusted EBITDA projected at \$318 million to \$322 million.
  • Gross Margin targeted at 33.3%.
• Solid National Footprint:
  • 366 Locations across 38 states.
  • 29,000 Caregivers providing 46.1 million homecare hours annually.
  • 93 preferred payors and no single payor contributing more than 10% of total revenue, reflecting a diversified payor mix.
• Growth Strategy:
  • Focus on value-based agreements and preferred payor partnerships.
  • Significant investments in a scalable, data-driven homecare platform to support value-based care and achieve cost savings for partners.
  • Strategic tuck-in acquisitions and ongoing national expansion.

Business Segment Performance Details

Private Duty Services (PDS)

• FY 2025 Net Revenue: \$2,001 million
• Gross Margin: 26–28%
• Organic Growth Rate: 3–5%
• 257 locations in 29 states; 57% of PP volume from preferred payors.
• 30 preferred payor partnerships with enhanced rates and value-based agreements.
• Recruiting platform and technology investments to support caregiver hiring and data-driven outcomes.

Home Health & Hospice (HHH)

• FY 2025 Net Revenue: \$249 million
• Gross Margin: 50–52%
• Organic Growth Rate: 5–7%
• 82 locations across 15 states, serving 14,800 patients.
• 77% of Home Health payors are preferred (episodic agreements); organic growth initiatives aligned with preferred payor strategy.

Medical Solutions (MS)

• FY 2025 Net Revenue: \$184 million
• Gross Margin: 42–44%
• Organic Growth Rate: 8–11%
• 27 states served, 30,700 patients, 18 preferred payors.
• Nationally scaled provider of enteral nutrition and medical supplies with strong patient demand and average case length of 2–3 years.

Strategic Initiatives and Market Opportunity

• Aveanna’s Transformative Homecare Platform: The company’s advanced, data-driven homecare platform is positioned to deliver improved clinical outcomes and introduce value-based agreements that drive cost savings for partners.
• Value-Based Organic and M&A Growth:
  • Long-term revenue growth targeted at 7–10% per annum.
  • Organic growth of 2.5–4% and value-based growth of 3.5–4.5%.
  • Strategic tuck-in acquisitions to strengthen offerings to key payor and government partners.
• Large Addressable Market:
  • \$119 billion U.S. homecare market opportunity, with significant untapped demand in private duty nursing and expansion of family caregiver programs.
  • Fragmented market supports sustainable growth, with only a fraction of eligible children and adults currently receiving needed care.

Financial Performance and Capital Structure

• Improved Profitability: Adjusted EBITDA margin improved year-over-year, reflecting operating leverage and disciplined cost management.
• Healthy Liquidity and Leverage Profile:
  • Liquidity of \$528.8 million supports ongoing growth investments.
  • Interest rate hedges in place for \$520 million (swap) and \$880 million (cap) to mitigate exposure to rising rates.
• Non-GAAP Measures: Company uses Adjusted EBITDA, Normalized Adjusted EBITDA, and Free Cash Flow as key performance indicators, but notes these are non-GAAP metrics and should be considered supplemental to GAAP results.

Leadership Updates

• Jeff Shaner, CEO: Instrumental in Aveanna’s formation and strategic direction, leading the company since 2023.
• Matt Buckhalter, CFO: Integral to Aveanna’s financial structure since inception and oversees investor relations.
• Debbie Stewart, Principal Accounting Officer: Leads accounting, tax, SEC reporting, and internal audit functions.

Potential Price-Sensitive Items for Shareholders

• Strong growth trajectory and margin expansion in all core segments could drive positive investor sentiment and share price appreciation.
• Ongoing investments in technology, value-based care, and M&A may lead to further operational efficiencies and market share gains.
• Significant liquidity and hedging strategy reduce financial risk, supporting continued growth and financial flexibility.
• Large, growing addressable market with policy and demographic tailwinds offers long-term upside for investors.

Disclaimer

This article is for informational purposes only and does not constitute investment, legal, tax, or financial advice. Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially. Investors should refer to Aveanna’s official filings with the SEC for more detailed risk factors and consult their financial advisors before making investment decisions.

View Aveanna Healthcare Holdings, Inc. Historical chart here